glp 1 agonist medullary thyroid cancer Does Using GLP-1 Drugs, Like Zepbound or Wegovy, Increase Your Risk of Cancer? Can Semaglutide Cause Cancer? Know

J.ThomsenM

A 2022 study published in Diabetes, Obesity and Metabolism found that adults over 50 achieved clinically significant weight loss on semaglutide, with cardiovascular and metabolic risk reductions comparable to younger cohorts, though the authors noted the importance of individualized monitoring protocols for older patients given the higher baseline prevalence of comorbidities

How Are These Medications Different

30 , 31 The FLOW trial demonstrated that, compared to placebo, randomization to semaglutide reduced the risk of kidney-related complications by 24% (HR: 0.76, 95% CI 0.66, 0.88) in patients with diabetes and chronic kidney disease

[DOI] [PubMed] [Google Scholar] 55.Moore B

The dose escalation schedule followed a gradual increase pattern designed to minimize gastrointestinal side effects while allowing researchers to identify optimal therapeutic ranges